New Jersey had what BioNJ called a “banner week” last week with four life sciences companies choosing New Jersey as their new home.
One was Germany-based Evotec, which is making Princeton its new U.S. headquarters. The company already has a location in Princeton, but the East Coast main office is currently in Connecticut.
According to BioNJ, the company has committed to opening its U.S. headquarters in New Jersey.
The second is Spanish pharmaceutical HIPRA, a veterinary company which already has a campus in Glassboro, but is establishing its North American headquarters at Rowan University’s Technology Park in Mantua Township.
The location is roughly one mile away from its current location and is slated to take up about 25 acres of the existing 180 acres in the park, according to a statement from Rowan.
“The United States is a critical market for our firm and its continued growth,” said Arnau Nogareda, HIPRA’s managing director, in a statement. “The South Jersey Technology Park will provide us with an ideal location to expand our operations in the United States and distribute our products worldwide as well as help us find our future workforce, including from among Rowan University graduates. We selected the Technology Park after evaluating numerous first-class host sites. We were impressed by the research already being done at Rowan and the Technology Park, in particular in the areas of science and engineering; access to outstanding faculty and student teams; support from New Jersey, Gloucester County and Mantua Township; and a location in the heart of the East Coast.”
The third company to choose the Garden State as its new U.S. location is Biocartis.
In a statement last week, the company — which focuses on innovative oncology products — announced the new location in “the New Jersey area” as well as appointing Vishal Sikri as its U.S. general manager.
Debbie Hart, CEO and president of BioNJ, said the week was a win for New Jersey and job creation in the state.
“This is a big win for New Jersey. These companies will create jobs, both direct and indirect, ultimately boosting New Jersey’s economy,” Hart said. “Their decisions to locate here further enforce and enhance the attractiveness of New Jersey as an innovation and commercialization hub for the life sciences industry. Meanwhile, each will play an important role in bolstering medical innovation — advancing innovation and new therapies and cures for patients (and animals) around the world.”
The fourth company is San Diego based ACADIA Pharmaceuticals announced Wednesday they were opening a location in Princeton.